Cai Grau

DMSc, Klinisk professor

Profile photoCai Grau
Professor, overlæge, dr. med.
Kræftafdelingen og
Dansk Center for Partikelterapi
Aarhus Universitetshospital
Palle Juul-Jensens Boulevard 25, indgang B3
DK-8200 Aarhus N
Danmark
Tel +4578456436

Fødselsår

1958

Uddannelser

1998Board certified specialist in oncology (radiation oncology and medical oncology), Danmark
1994Doctor of Medical Science, Medical School, Aarhus University Hospital, Danmark
1987Candidate of Medicine, Medical School, Aarhus Universitetshospital, Danmark

Akademiske grader

1994Dr. med., det sundhedsvidenskabelige fakultet, Aarhus Universitet, Danmark

Forskningsområder

Klinisk strålebehandling og strålebiologi, Partikelterapi, hoved-halskræft, brystkræft, spiserørskræft, billedvejledt, stereotaktisk og adaptive strålebehandling, senfølger, funktionel billeddannelse, sundheds-økonomi.

Publikationer og præsentationer

Publikationer: 220+, Peer-reviewed: 200+, Bogkapitler: 10, Præsentationer ved videnskabelige møder (oral): 300+.

Udvalgs- og bestyrelsesposter

Leder af det nationale forskningscenter Danish Comprehensive Cancer Center - Radiotherapy (DCCC-RT)
Formand, ESTRO task force om Health Economics in Radiation Oncology (HERO)
Formand, European Particle Therapy Network (EPTN)
Formand, Fagligt Udvalg i Danish Comprehensive Cancer Centre (DCCC)
Næstformand, Scientific Advisory Board for Helmholz Zentrum Dresden-Rössendorf (HZDR)
Scientific Audit Committee of EORTC 2015-2020
Formand, stråleterapi kvalitetssikringsgruppen under Danish Head and Neck Cancer Group (DAHANCA)

Kræftens Bekæmpelse Videnskabelige Udvalg (KBVU) 2011-2017, formand 2016-17
Forretningsudvalget, European Head and Neck Society (EHNS) 2010-2018
Præsident, Scandinavian Society for Head and Neck Oncology (SSHNO) 2012-2016
Formand, Dansk Selskab for Klinisk Onkologi (DSKO) 2006-2008
Danish Council for Independent Research | Medical Sciences (FSS) 2008-2013

Organisering af kliniske forsøg

DAHANCA35: National randomiseret studie protoner hoved-halskræft (planlagt 500 patienter) 2020-2024
DBCG Proton: National randomiseret studie protoner brystkræft (planlagt 1500 patients) 2020-2025
PROTECT: Internationalt randomiseret studie protoner spiserørskræft (planlagt 440 patienter) 2021-2024
DAHANCA 10 National RCT in head and neck cancer (522 patients) 2002-2006
IAEA-ACC (CRP E.3.30.18): International RCT 908 hoved-halskræft (koordinator, data manager) 1999-2004
IAEA-MMC (CRP E.3.30.13): International RCT 558 hoved-halskræft (koordinator, data manager) 1996-1999

Vejledning og bedømmelser

Vejleder for 23 PhD/dr.med. projekter (5 igangværende). Medlem af bedømmelsesudvalg for 24 PhD and dr. med. afhandlinger.

Priser og udmærkelser

ESTRO Emmanuel Vander Schueren Award 2015
European Head and Neck Society Award 2018
ABRO-BVRO Emmanuel van der Schueren Lecture, Belgium 2014
R.M. Tiwari Award Lecture, Foundation of Head and Neck Oncology India 2014
Onkologiprisen - Danish Society for Clinical Oncology 2012

Større forskningsbevillinger

Hovedansøger på bevillinger fra Kræftens Bekæmpelse siden 2003; Novo Nordisk Fonden 2019; AUH Strategisk Udvikling 2018; Danmarks Frie Forskningsråd (FSS) 2004, 2010, 2011; Varian Medical Systems siden 2005; forskningsaccelerator fra A.P. Møller Fonden 2008; Lundbeck Funden og Strategisk Forskningsråd 2009; totalt DKK 200 mil (€26 mil) siden 2003.

Ekstern bedømmer for fonde

Danish Medical Research Council (FSS) (2007-2013)
Varian Medical Systems 2011-)
The Danish National Advanced Technology Foundation [Højteknologifonden] (2011)
Hercules Foundation Belgium (2008-2011)
Kreftforeningen Norway (2011)
Flemish League Against Cancer (2011)
The Norwegian Radium Hospital (2010)
Margarete von Wrangell-Habilitationsprogramm (2008)
Austrian Academy of Sciences (2008)
Emmanuel van der Schueren Foundation Belgium (2008)
Austrian National Bank Jubilee Foundation (2008)
The Dutch Cancer Society (2006)
Linköping University (2005)
Swedish Medical Research Council (2004)

Medlemsskaber

European Head and Neck Society (EHNS)
Danish Society for Clinical Oncology DSKO
Danish Society for Clinical Oncology DSKO
European Society for Therapeutic Radiology and Oncology ESTRO
Danish Society for Head and Neck Oncology DSHHO
Danish Society for Head and Neck Oncology DSHHO
Scandinavian Society for Head and Neck Oncology SSHNO
Scandinavian Society for Head and Neck Oncology SSHNO
Danish Society for Cancer Research
International Federation of Head and Neck Oncology Societies IFHNOS Canadian Association of Radiation Oncologists (CARO)
American Society for Therapeutic Radiology and Oncology (ASTRO)
Danish Society for Medical Physics (DSMF)

Publikationer

MACH-NC and MARCH Collaborative Groups. 2021. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. The Lancet Oncology. https://doi.org/10.1016/S1470-2045(21)00076-0
Nyeng TB, Møller DS, Farr K, Kramer S, Khalil AA, Grau C, Hoffmann L. 2021. A comparison of two methods for segmentation of functional volumes in radiotherapy planning of lung cancer patients. Acta Oncologica. 60(3):353-360. https://doi.org/10.1080/0284186X.2021.1877811
Sharma MB, Argota Perez R, Holm AIS, Korreman SS, Jensen K, Elstrøm UV, Grau C. 2021. Air variability in maxillary sinus during radiotherapy for sinonasal carcinoma. Clinical and Translational Radiation Oncology. 27:36-43. https://doi.org/10.1016/j.ctro.2020.12.007
Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS, Burtness B, Ghi MG, Cohen EEW, Grau C, Wolf G, Hitt R, Corvò R, Budach V, Kumar S, Laskar SG, Mazeron JJ, Zhong LP, Dobrowsky W, Ghadjar P, Fallai C, Zakotnik B, Sharma A, Bensadoun RJ, Ruo Redda MG, Racadot S, Fountzilas G, Brizel D, Rovea P, Argiris A, Nagy ZT, Lee JW, Fortpied C, Harris J, Bourhis J, Aupérin A, Blanchard P, Pignon JP, MACH-NC Collaborative Group. 2021. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group. Radiotherapy and Oncology. 156:281-293. https://doi.org/10.1016/j.radonc.2021.01.013
Høyer M, Grau C. 2021. Research in radiation oncology and the Covid-19 pandemic. Acta Oncologica. 60(3):275-276. https://doi.org/10.1080/0284186X.2021.1890334
EHNS Executive Board, ESMO Guidelines Committee, ESTRO Executive Board. 2021. Reprint of "Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Oral Oncology. 113:105042. https://doi.org/10.1016/j.oraloncology.2020.105042
Korreman S, Eriksen JG, Grau C. 2021. The changing role of radiation oncology professionals in a world of AI – Just jobs lost – Or a solution to the under-provision of radiotherapy?. Clinical and Translational Radiation Oncology. 26:104-107. https://doi.org/10.1016/j.ctro.2020.04.012
Gerlach S, Pinto M, Kurichiyanil N, Grau C, Hérault J, Hillbrand M, Poulsen PR, Safai S, Schippers JM, Schwarz M, S ndergaard CS, Tommasino F, Verroi E, Vidal M, Yohannes I, Schreiber J, Parodi K. 2020. Beam characterization and feasibility study for a small animal irradiation platform at clinical proton therapy facilities. Physics in Medicine and Biology. 65(24):Article 245045. https://doi.org/10.1088/1361-6560/abc832
Sharma MB, Jensen K, Amidi A, Eskildsen SF, Johansen J, Grau C. 2020. Late toxicity in the brain after radiotherapy for sinonasal cancer: Neurocognitive functioning, MRI of the brain and quality of life. Clinical and Translational Radiation Oncology. 25:52-60. https://doi.org/10.1016/j.ctro.2020.09.003
Machiels J-P, René Leemans C, Golusinski W, Grau C, Licitra L, Gregoire V, EHNS Executive Board, ESMO Guidelines Committee, ESTRO. 2020. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology. 31(11):1462-1475. https://doi.org/10.1016/j.annonc.2020.07.011
Witt Nyström P, Bratland Å, Minn H, Grau C. 2020. Ongoing and future clinical trials in particle therapy in the Nordic countries. Acta oncologica (Stockholm, Sweden). 59(10):1145-1150 . https://doi.org/10.1080/0284186X.2020.1792548
Chan J, Friborg J, Zubizarreta E, van Eck JW, Hanna TP, Bourque JM, Gaudet M, Dennis K, Olson R, Coleman CN, Petersen AJ, Grau C, Abdel-Wahab M, Brundage M, Slotman B, Polo A. 2020. Examining geographic accessibility to radiotherapy in Canada and Greenland for indigenous populations: Measuring inequities to inform solutions. Radiotherapy and Oncology. 146:1-8. https://doi.org/10.1016/j.radonc.2020.01.023
Poulsen PR, Murtaza G, Worm ES, Ravkilde T, O'Brien R, Grau C, Høyer M, Keall P. 2020. Simulated multileaf collimator tracking for stereotactic liver radiotherapy guided by kilovoltage intrafraction monitoring: Dosimetric gain and target overdose trends. Radiotherapy and Oncology. 144:93-100. https://doi.org/10.1016/j.radonc.2019.11.008
Sharma MB, Jensen K, Urbak SF, Funding M, Johansen J, Bechtold D, Amidi A, Eskildsen SF, Jørgensen JOL, Grau C. 2020. A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer. Radiotherapy & Oncology. 151:58-65. https://doi.org/10.1016/j.radonc.2020.07.029
Weber DC, Langendijk JA, Grau C, Thariat J. 2020. Proton therapy and the European Particle Therapy Network: The past, present and future. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 24(6-7):687-690. https://doi.org/10.1016/j.canrad.2020.05.002
Jensen K, Friborg J, Hansen CR, Samsøe E, Johansen J, Andersen M, Smulders B, Andersen E, Nielsen MS, Eriksen JG, Petersen JBB, Elstrøm UV, Holm AI, Farhadi M, Morthorst MH, Skyt PS, Overgaard J, Grau C. 2020. The Danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines. Radiotherapy & Oncology. 151:149-151. https://doi.org/10.1016/j.radonc.2020.07.037
Thomas G, Eisenhauer E, Bristow RG, Grau C, Hurkmans C, Ost P, Guckenberger M, Deutsch E, Lacombe D, Weber DC, European Organisation for Research and Treatment of Cancer (EORTC). 2020. The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report. European Journal of Cancer. 131:76-88. https://doi.org/10.1016/j.ejca.2020.02.050
Lee AW, Ng WT, Pan JJ, Chiang C-L, Poh SS, Choi HC, Chan Ahn Y, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Sanguineti G, Soong YL, Tao Y, Yom SS, Wee JT. 2019. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma. International Journal of Radiation Oncology, Biology, Physics. 105(3):567-580. https://doi.org/10.1016/j.ijrobp.2019.06.2540
Hansen CR, Friborg J, Jensen K, Samsøe E, Johnsen L, Zukauskaite R, Grau C, Maare C, Johansen J, Primdahl H, Bratland, Kristensen CA, Andersen M, Eriksen JG, Overgaard J. 2019. NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy. Acta Oncologica. 58(10):1410-1415. https://doi.org/10.1080/0284186X.2019.1654129
Defourny N, Perrier L, Borras JM, Coffey M, Corral J, Hoozée S, Loon JV, Grau C, Lievens Y. 2019. National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO project. Radiotherapy and Oncology. 138:187-194. https://doi.org/10.1016/j.radonc.2019.06.015
Biau J, Lapeyre M, Troussier I, Budach W, Giralt J, Grau C, Kazmierska J, Langendijk JA, Ozsahin M, O'Sullivan B, Bourhis J, Grégoire V. 2019. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiotherapy and Oncology. 134:1-9. https://doi.org/10.1016/j.radonc.2019.01.018
Weber DC, Grau C, Lim PS, Georg D, Lievens Y. 2019. Bringing Europe together in building clinical evidence for proton therapy - the EPTN-ESTRO-EORTC endeavor. Acta Oncologica. 58(10):1340-1342. https://doi.org/10.1080/0284186X.2019.1624820
Farr KP, Khalil AA, Grau C. 2019. Patient-reported lung symptoms and quality of life before and after radiation therapy for non-small cell lung cancer: correlation with radiation pneumonitis and functional imaging. Acta Oncologica. 58(10):1523-1527. https://doi.org/10.1080/0284186X.2019.1634835
Mortensen HR, Høyer M, Grau C. 2019. Protonbehandling. Ugeskrift for Læger . 181(20):Article V04190243.
Grégoire V, Grau C, Lapeyre M, Maingon P. 2018. Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma. Oral Oncology. 87:131-137. https://doi.org/10.1016/j.oraloncology.2018.10.034
Andreassen CN, Eriksen JG, Jensen K, Hansen CR, Sørensen BS, Lassen P, Alsner J, Schack LMH, Overgaard J, Grau C. 2018. IMRT – Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer. Oral Oncology. 86:91-99. https://doi.org/10.1016/j.oraloncology.2018.09.001
Grau C, Baumann M, Weber DC. 2018. Optimizing clinical researchIntroducing the European Particle Therapy Network (EPTN) and generating prospective high-quality data in particle therapy in Europe:. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 128(1):1-3. https://doi.org/10.1016/j.radonc.2018.06.021
Langendijk JA, Orecchia R, Haustermans K, Zips D, Balosso J, Lacombe D, Lievens Y, Weber DC, Grau C, Troost EGC. 2018. Prospective data registration and clinical trials for particle therapy in Europe. Radiotherapy and Oncology. 128(1):9-13. https://doi.org/10.1016/j.radonc.2018.06.001
Worm ES, Høyer M, Hansen R, Larsen LP, Weber B, Grau C, Poulsen PR. 2018. A Prospective Cohort Study of Gated Stereotactic Liver Radiation Therapy Using Continuous Internal Electromagnetic Motion Monitoring. International Journal of Radiation Oncology, Biology, Physics. 101(2). https://doi.org/10.1016/j.ijrobp.2018.02.010
Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C. 2018. DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group. Radiotherapy & Oncology. 127(1):12-19. https://doi.org/10.1016/j.radonc.2018.02.018
Taasti VT, Muren L, Jensen K, Petersen JBB, Thygesen J, Tietze A, Grau C, Hansen DC. 2018. Comparison of single and dual energy CT for stopping power determination in proton therapy of head and neck cancer. Physics and Imaging in Radiation Oncology. 6:14-19. https://doi.org/10.1016/j.phro.2018.04.002
Hvid CA, Elstrøm UV, Jensen K, Grau C. 2018. Cone-beam computed tomography (CBCT) for adaptive image guided head and neck radiation therapy. Acta Oncologica. 57(4):552-556. https://doi.org/10.1080/0284186X.2017.1398414
Borras JM, Grau C, Corral J, Wong K, Barton MB, Ferlay J, Bray F, Lievens Y. 2018. Estimating the number of fractions by tumour site for European countries in 2012 and 2025: An ESTRO-HERO analysis. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 126(2):198-204. https://doi.org/10.1016/j.radonc.2017.11.009
Farr KP, Khalil AA, Møller DS, Bluhme H, Kramer S, Morsing A, Grau C. 2018. Time and dose-related changes in lung perfusion after definitive radiotherapy for NSCLC. Radiotherapy & Oncology. 126(2):307-311. https://doi.org/10.1016/j.radonc.2017.11.008
Hansen CR, Johansen J, Samsøe E, Andersen E, Petersen JBB, Jensen K, Andersen LJ, Sand HMB, Bertelsen AS, Grau C. 2018. Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy. Radiotherapy & Oncology. 126(1):43-47. https://doi.org/10.1016/j.radonc.2017.09.019
Grégoire V, Evans M, Le Q-T, Bourhis J, Budach V, Chen A, Eisbruch A, Feng M, Giralt J, Gupta T, Hamoir M, Helito JK, Hu C, Hunter K, Johansen J, Kaanders J, Laskar SG, Lee A, Maingon P, Mäkitie A, Micciche' F, Nicolai P, O'Sullivan B, Poitevin A, Porceddu S, Składowski K, Tribius S, Waldron J, Wee J, Yao M, Yom SS, Zimmermann F, Grau C. 2018. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiotherapy & Oncology. 126(1):3-24. https://doi.org/10.1016/j.radonc.2017.10.016
Zukauskaite R, Hansen CR, Grau C, Samsøe E, Johansen J, Petersen JBB, Andersen E, Brink C, Overgaard J, Eriksen JG. 2018. Local recurrences after curative IMRT for HNSCC. Radiotherapy & Oncology. 126(1):48-55. https://doi.org/10.1016/j.radonc.2017.11.024
Lee AW, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Soong YL, Tao Y, Yom SS, Wee JT. 2018. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiotherapy & Oncology. 126(1):25-36. https://doi.org/10.1016/j.radonc.2017.10.032
Zukauskaite R, Hansen CR, Brink C, Johansen J, Asmussen JT, Grau C, Overgaard J, Eriksen JG. 2017. Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods. Acta Oncologica. 56(11):1554-1561. https://doi.org/10.1080/0284186X.2017.1346384
Grau C, Høyer M, Poulsen PR, Muren LP, Korreman SS, Tanderup K, Lindegaard JC, Alsner J, Overgaard J. 2017. Rethink radiotherapy - BIGART 2017. Acta Oncologica. 56(11):1341-1352. https://doi.org/10.1080/0284186X.2017.1371326
Lacas B, Bourhis J, Overgaard J, Zhang Q, Grégoire V, Nankivell M, Zackrisson B, Szutkowski Z, Suwiński R, Poulsen M, O'Sullivan B, Corvò R, Laskar SG, Fallai C, Yamazaki H, Dobrowsky W, Cho KH, Garden AS, Langendijk JA, Viegas CMP, Hay J, Lotayef M, Parmar MKB, Aupérin A, van Herpen C, Maingon P, Trotti AM, Grau C, Pignon JP, Blanchard P. 2017. Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis. Lancet Oncology. 18(9):1221-1237. https://doi.org/10.1016/S1470-2045(17)30458-8
Ellegaard MBB, Grau C, Zachariae R, Jensen AB. 2017. Women with breast cancer report substantially more disease- and treatment-related side or late effects than registered by clinical oncologists: a cross-sectional study of a standard follow-up program in an oncological department. Breast Cancer Research and Treatment. 164(3):727-736. https://doi.org/10.1007/s10549-017-4301-x
Weber DC, Abrunhosa-Branquinho A, Bolsi A, Kacperek A, Dendale R, Geismar D, Bachtiary B, Hall A, Heufelder J, Herfarth K, Debus J, Amichetti M, Krause M, Orecchia R, Vondracek V, Thariat J, Kajdrowicz T, Nilsson K, Grau C. 2017. Profile of European proton and carbon ion therapy centers assessed by the EORTC facility questionnaire. Radiotherapy and Oncology. 124(2):185-189. https://doi.org/10.1016/j.radonc.2017.07.012
Ellegaard M-BB, Grau C, Zachariae R, Bonde Jensen A. 2017. Fear of cancer recurrence and unmet needs among breast cancer survivors in the first five years. A cross-sectional study. Acta Oncologica. 56(2):314-320. https://doi.org/10.1080/0284186X.2016.1268714
Defourny N, Dunscombe P, Perrier L, Grau C, Lievens Y. 2016. Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis. Radiotherapy & Oncology. 121(3):468-474. https://doi.org/10.1016/j.radonc.2016.12.002
Hvid CA, Elstrøm UV, Jensen K, Alber M, Grau C. 2016. Accuracy of software-assisted contour propagation from planning CT to cone beam CT in head and neck radiotherapy. Acta Oncologica. 55(11):1324-1330. https://doi.org/10.1080/0284186X.2016.1185149
Zukauskaite R, Brink C, Hansen CR, Bertelsen A, Johansen J, Grau C, Eriksen JG. 2016. Open source deformable image registration system for treatment planning and recurrence CT scans: Validation in the head and neck region. Strahlentherapie und Onkologie. 192(8):545-551. https://doi.org/10.1007/s00066-016-0998-4
Taasti VT, Høye EM, Hansen DC, Muren L, Thygesen J, Skyt PS, Balling P, Bassler N, Grau C, Mierzwinska G, Rydygier M, Swakon J, Petersen JBB. 2016. Technical Note: Improving proton stopping power ratio determination for a deformable silicone-based 3D dosimeter using dual energy CT. Medical Physics. 43(6):Article 2780. https://doi.org/10.1118/1.4948677
Hansen R, Ravkilde T, Worm ES, Toftegaard J, Grau C, Macek K, Poulsen PR. 2016. Electromagnetic guided couch and multileaf collimator tracking on a TrueBeam accelerator. Medical Physics. 43(5):2387-2398. https://doi.org/10.1118/1.4946815
Pagh A, Grau C, Overgaard J. 2016. Failure pattern and salvage treatment after radical treatment of head and neck cancer. Acta Oncologica. 55(5):625-32. https://doi.org/10.3109/0284186X.2015.1117136
Borras JM, Lievens Y, Barton M, Corral J, Ferlay J, Bray F, Grau C. 2016. How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis. Radiotherapy & Oncology. 119(1):5-11. https://doi.org/10.1016/j.radonc.2016.02.016
Mortensen H, Grau C. 2015. Flere patienter med hoved-hals-kræft bør henvises til rehabilitering af synkefunktionen. Ugeskrift for Laeger. 177(44):Article V67477.
Grau C, Overgaard J, Høyer M, Tanderup K, Lindegaard JC, Muren LP. 2015. Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality. Acta Oncologica. 54(9):1245-50. https://doi.org/10.3109/0284186X.2015.1076992
Farr KP, Kallehauge JF, Møller DS, Khalil AA, Kramer S, Bluhme H, Morsing A, Grau C. 2015. Inclusion of functional information from perfusion SPECT improves predictive value of dose-volume parameters in lung toxicity outcome after radiotherapy for non-small cell lung cancer: A prospective study. Radiotherapy & Oncology. 117(1):9-16. https://doi.org/10.1016/j.radonc.2015.08.005
Farr KP, Møller DS, Khalil AA, Kramer S, Morsing A, Grau C. 2015. Loss of lung function after chemo-radiotherapy for NSCLC measured by perfusion SPECT/CT: Correlation with radiation dose and clinical morbidity. Acta Oncologica. 54(9):1350-4. https://doi.org/10.3109/0284186X.2015.1061695
Hansen CR, Johansen J, Kristensen CA, Smulders B, Andersen LJ, Samsøe E, Andersen E, Petersen JBB, Overgaard J, Grau C. 2015. Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial. Acta Oncologica. 54(9):1669-73. https://doi.org/10.3109/0284186X.2015.1063780
Metwally MAH, Ali R, Kuddu M, Shouman T, Strojan P, Overgaard J, Grau C. 2015. Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole. Acta Oncologica. 54(9):1673-7. https://doi.org/10.3109/0284186X.2015.1074721
Poulsen PR, Worm ES, Hansen R, Larsen LPS, Grau C, Høyer M. 2015. Respiratory gating based on internal electromagnetic motion monitoring during stereotactic liver radiation therapy: First results. Acta Oncologica. 54(9):1445-52. https://doi.org/10.3109/0284186X.2015.1062134
Lievens Y, Borras JM, Grau C. 2015. Cost calculation - a necessary step towards widespread adoption of advanced radiotherapy technology. Acta Oncologica. 54(9):1275-1281. https://doi.org/10.3109/0284186X.2015.1066932
Borras JM, Lievens Y, Grau C. 2015. The need for radiotherapy in Europe in 2020. Not only data but also a cancer plan. Acta Oncologica. 54(9):1268-74. https://doi.org/10.3109/0284186X.2015.1062139
Brouwer CL, Steenbakkers RJHM, Bourhis J, Budach W, Grau C, Grégoire V, van Herk M, Lee A, Maingon P, Nutting C, O'Sullivan B, Porceddu SV, Rosenthal DI, Sijtsema NM, Langendijk JA. 2015. CT-based delineation of organs at risk in the head and neck region.DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiotherapy & Oncology. 117(1):83-90. https://doi.org/10.1016/j.radonc.2015.07.041
Boejen A, Vestergaard A, Hoffmann L, Ellegaard M-B, Rasmussen A-M, Møller D, Muren LP, Grau C. 2015. A learning programme qualifying radiation therapists to manage daily online adaptive radiotherapy. Acta Oncologica. 54(9):1697-1701. https://doi.org/10.3109/0284186X.2015.1062914
Metwally MAH, Ali R, Kuddu M, Shouman T, Strojan P, Iqbal K, Prasad R, Grau C, Overgaard J. 2015. IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma. Radiotherapy & Oncology. 116(1):15-20. https://doi.org/10.1016/j.radonc.2015.04.005
Farr KP, Kramer S, Khalil AA, Morsing A, Grau C. 2015. Role of perfusion SPECT in prediction and measurement of pulmonary complications after radiotherapy for lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 42(8):1315-24. https://doi.org/10.1007/s00259-015-3052-3
Borras JM, Barton M, Grau C, Corral J, Verhoeven R, Lemmens V, van Eycken L, Henau K, Primic-Zakelj M, Strojan P, Trojanowski M, Dyzmann-Sroka A, Kubiak A, Gasparotto C, Defourny N, Malicki J, Dunscombe P, Coffey M, Lievens Y. 2015. The impact of cancer incidence and stage on optimal utilization of radiotherapy. Methodology of a population based analysis by the ESTRO-HERO project. Radiotherapy & Oncology. 116(1):45-50. https://doi.org/10.1016/j.radonc.2015.04.021
Borras JM, Lievens Y, Dunscombe P, Coffey M, Malicki J, Corral J, Gasparotto C, Defourny N, Barton M, Verhoeven R, van Eycken L, Primic-Zakelj M, Trojanowski M, Strojan P, Grau C. 2015. The optimal utilization proportion of external beam radiotherapy in European countries. An ESTRO-HERO analysis. Radiotherapy & Oncology. 116(1):38-44. https://doi.org/10.1016/j.radonc.2015.04.018
Pagh A, Grau C, Overgaard J. 2015. A longitudinal study of follow-up activities after curative treatment for head and neck cancer. Acta Oncologica. 54(5):813-9. https://doi.org/10.3109/0284186X.2015.1028591
Lievens Y, Dunscombe P, Defourny N, Gasparotto C, Borras JM, Grau C. 2015. HERO (Health Economics in Radiation Oncology): A Pan-European Project on Radiotherapy Resources and Needs. Clinical Oncology. 27(2):115-24. https://doi.org/10.1016/j.clon.2014.10.010
Mortensen HR, Jensen K, Aksglæde K, Lambertsen K, Eriksen E, Grau C. 2015. Prophylactic Swallowing Exercises in Head and Neck Cancer Radiotherapy. Dysphagia. 30(3):304-14. https://doi.org/10.1007/s00455-015-9600-y
Ravkilde T, Keall PJ, Grau C, Høyer M, Poulsen PR. 2014. Fast motion-including dose error reconstruction for VMAT with and without MLC tracking. Physics in Medicine and Biology. 59(23):7279-7296. https://doi.org/10.1088/0031-9155/59/23/7279
Skripcak T, Belka C, Bosch W, Brink C, Brunner T, Budach V, Büttner D, Debus J, Dekker A, Grau C, Gulliford S, Hurkmans C, Just U, Krause M, Lambin P, Langendijk JA, Lewensohn R, Lühr A, Maingon P, Masucci M, Niyazi M, Poortmans P, Simon M, Schmidberger H, Spezi E, Stuschke M, Valentini V, Verheij M, Whitfield G, Zackrisson B, Zips D, Baumann M. 2014. Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets. Radiotherapy & Oncology. 113(3):303-9. https://doi.org/10.1016/j.radonc.2014.10.001
HERO Consortium. 2014. Guidelines for equipment and staffing of radiotherapy facilities in the European countries: Final results of the ESTRO-HERO survey. Radiotherapy & Oncology. https://doi.org/10.1016/j.radonc.2014.08.032
HERO Consortium. 2014. Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey. Radiotherapy & Oncology. 112(2):155-64. https://doi.org/10.1016/j.radonc.2014.08.029
Poulsen PR, Worm ES, Petersen JBB, Grau C, Fledelius W, Høyer M. 2014. Kilovoltage intrafraction motion monitoring and target dose reconstruction for stereotactic volumetric modulated arc therapy of tumors in the liver. Radiotherapy & Oncology. https://doi.org/10.1016/j.radonc.2014.05.007
Elstrøm UV, Olsen SK, Muren LP, Petersen JBB, Grau C. 2014. The impact of CBCT reconstruction and calibration for radiotherapy planning in the head and neck region - a phantom study. Acta Oncologica. 1-11. https://doi.org/10.3109/0284186X.2014.927073
Fledelius W, Worm ES, Høyer M, Grau C, Poulsen PR. 2014. Real-time segmentation of multiple implanted cylindrical liver markers in kilovoltage and megavoltage x-ray images. Physics in Medicine and Biology. 59(11):2787-2800. https://doi.org/10.1088/0031-9155/59/11/2787
Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le Q-T, Maingon P, Nutting C, O'Sullivan B, Porceddu SV, Lengele B. 2014. Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiotherapy & Oncology. 172-81. https://doi.org/10.1016/j.radonc.2013.10.010
HERO Consortium. 2014. Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey. Radiotherapy & Oncology. https://doi.org/10.1016/j.radonc.2014.08.034
Ravkilde T, Keall PJ, Grau C, Høyer M, Poulsen PR. 2013. Time-resolved dose distributions to moving targets during volumetric modulated arc therapy with and without dynamic MLC tracking. Medical Physics. 40(11):Article 111723. https://doi.org/10.1118/1.4826161
Grau C, Høyer M, Alber M, Overgaard J, Lindegaard JC, Muren LP. 2013. Biology-guided adaptive radiotherapy (BiGART) - more than a vision?. Acta Oncologica. 52(7):1243-7. https://doi.org/10.3109/0284186X.2013.829245
Farr KP, Khalil AA, Knap MM, Møller DS, Grau C. 2013. Development of radiation pneumopathy and generalised radiological changes after radiotherapy are independent negative prognostic factors for survival in non-small cell lung cancer patients. Radiotherapy & Oncology. 107(3):382-388. https://doi.org/10.1016/j.radonc.2013.04.024
Grau C, Borras JM, Malicki J, Slotman B, Dunscombe P, Coffey M, Hollywood D, Guedea F, Gasparotto C, Lievens Y. 2013. Radiotherapy capacity in Europe. Lancet Oncology. 14(6):e196-8. https://doi.org/10.1016/S1470-2045(13)70069-X
Thörnqvist S, Muren LP, Bentzen L, Hysing LB, Høyer M, Grau C, Petersen JBB. 2013. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets. Acta Oncologica. 52(3):521-527. https://doi.org/10.3109/0284186X.2012.752860
Mortensen HR, Jensen K, Grau C. 2013. Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer. Acta Oncologica. 52(2):270-276. https://doi.org/10.3109/0284186X.2012.742205
Mortensen HR, Overgaard J, Jensen K, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen EV, Andersen LJ, Hansen H, Grau C. 2013. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer. Acta Oncologica. 52(7):1535-1542. https://doi.org/10.3109/0284186X.2013.824609
Mortensen HR, Jensen K, Aksglæde K, Behrens M, Grau C. 2013. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters. Radiotherapy & Oncology. 107(3):288-294. https://doi.org/10.1016/j.radonc.2013.06.001
Pagh A, Vedtofte T, Lynggaard CD, Rubek N, Lonka M, Johansen J, Andersen E, Kristensen CA, von Buchwald C, Andersen M, Godballe C, Overgaard J, Grau C. 2013. The value of routine follow-up after treatment for head and neck cancer. A National Survey from DAHANCA. Acta Oncologica. 52(2):277-84. https://doi.org/10.3109/0284186X.2012.741324
Ravkilde T, Keall PJ, Grau C, Høyer M, Poulsen PR. 2013. Time-resolved dose reconstruction by motion encoding of volumetric modulated arc therapy fields delivered with and without dynamic multi-leaf collimator tracking. Acta Oncologica. 52(7):1497-1503. https://doi.org/10.3109/0284186X.2013.818248
Lyhne NM, Christensen A, Alanin MC, Bruun MT, Jung TH, Bruhn MA, Jespersen JBB, Kristensen CA, Andersen E, Godballe C, Buchwald C, Bundgaard T, Johansen J, Lambertsen K, Primdahl H, Toustrup K, Sørensen JA, Overgaard J, Grau C. 2012. Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. European Journal of Cancer. 49(7):1627-1633. https://doi.org/10.1016/j.ejca.2012.11.034
Norling R, Grau C, Nielsen MB, Homøe P, Sørensen JA, Lambertsen K, Bundgaard T, Mäkitie A, Grénman R, Larenne J, Koivunen P, Virtaniemi J, Gudjonsson A, Jetlund O, Abendstein H, Rikardsen O, Lybak S, Wennerberg J, Högmo A, Laurell G, Westerborn A, Hammerlid E, Tytor W, Cederblad L, Von Buchwald C. 2012. Radiological imaging of the neck for initial decision-making in oral squamous cell carcinomas-A questionnaire survey in the Nordic countries. Acta Oncologica. 51(3):355-361. https://doi.org/10.3109/0284186X.2011.640346
Hoff CM, Grau C, Overgaard J. 2012. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma--a prospective study. Radiotherapy & Oncology. 103(1):38-44. https://doi.org/10.1016/j.radonc.2012.01.011
Lievens Y, Grau C. 2012. Health Economics in Radiation Oncology: Introducing the ESTRO HERO project. Radiotherapy & Oncology. https://doi.org/10.1016/j.radonc.2011.12.026
Mortensen HR, Overgaard J, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen LJ, Andersen EV, Grau C. 2012. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer. Radiotherapy & Oncology. 103(1):69-75. https://doi.org/10.1016/j.radonc.2012.01.002
Norling R, Grau C, Nielsen MB, Homøe P, Sørensen JA, Lambertsen K, Bundgaard T, Mäkitie A, Grénman R, Larenne J, Koivunen P, Virtaniemi J, Gudjonsson A, Jetlund O, Abendstein H, Rikardsen O, Lybak S, Wennerberg J, Högmo A, Laurell G, Westerborn A, Hammerlid E, Tytor W, Cederblad L, von Buchwald C. 2012. Radiological imaging of the neck for initial decision-making in oral squamous cell carcinomas-A questionnaire survey in the Nordic countries. Acta Oncologica. https://doi.org/10.3109/0284186X.2011.640346
Laursen LV, Elstrøm UV, Vestergaard A, Muren LP, Petersen JB, Lindegaard JC, Grau C, Tanderup K. 2012. Residual rotational set-up errors after daily cone-beam CT image guided radiotherapy of locally advanced cervical cancer. Radiotherapy & Oncology. 105(2):220-225. https://doi.org/10.1016/j.radonc.2012.08.012
Hoff C, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J. 2011. Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials. Acta Oncologica. 50(7):1006-1014. https://doi.org/10.3109/0284186X.2011.592650
Petersen JBB, Lassen Y, Hansen AT, Muren LP, Grau C, Høyer M. 2011. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours. Acta Oncologica. 50(6):823-828. https://doi.org/10.3109/0284186X.2011.590526
Toustrup K, Lambertsen K, Sørensen HB, Ulhøi B, Sørensen L, Grau C. 2011. Reduction in waiting time for diagnosis and treatment of head and neck cancer: a fast track study. Acta Oncologica. 50(5):636-642. https://doi.org/10.3109/0284186X.2010.551139
Hoff CM, Hansen HS, Overgaard M, Grau C, Johansen J, Bentzen J, Overgaard J. 2011. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy--results from the randomized DAHANCA 5 study. Radiotherapy & Oncology. 98(1):28-33. https://doi.org/10.1016/j.radonc.2010.09.024
Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen JKD, Andersen L, Evensen JF, Overgaard J. 2011. Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials. Acta Oncologica. 50(7):1006-14. https://doi.org/10.3109/0284186X.2011.592650
Elstrøm UV, Muren LP, Petersen JBB, Grau C. 2011. Evaluation of image quality for different kV cone-beam CT acquisition and reconstruction methods in the head and neck region. Acta Oncologica. 50(6):908-17. https://doi.org/10.3109/0284186X.2011.590525
Fledelius W, Worm ES, Elstrøm UV, Petersen JBB, Grau C, Høyer M, Poulsen PR. 2011. Robust automatic segmentation of multiple implanted cylindrical gold fiducial markers in cone-beam CT projections. Medical Physics. 38(12):6351. https://doi.org/10.1118/1.3658566
Aarts MCJ, Rovers MM, Grau C, Grolman W, van der Heijden GJM. 2011. Salvage laryngectomy after primary radiotherapy - what are prognostic factors for the development of pharyngocutaneous fistulae?. Otolaryngology - Head and Neck Surgery. 144(1):5-9. https://doi.org/10.1177/0194599810390914
Lassen P, Eriksen JG, Krogdahl A, Therkildsen MH, Ulhøi BP, Overgaard M, Specht L, Andersen EV, Johansen J, Andersen LJ, Grau C, Overgaard J, Danish Head and Neck Cancer Group (DAHANCA). 2011. The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial. Radiotherapy & Oncology. 100(1):49-55. https://doi.org/10.1016/j.radonc.2011.02.010
Søndergaard J, Olsen KØ, Muren L, Elstrøm UV, Grau C, Høyer M. 2010. A study of image-guided radiotherapy of bladder cancer based on lipiodol injection in the bladder wall. Acta Oncologica. 49(7):1109-1115. https://doi.org/10.3109/02841861003789491
Grau C, Olsen DR, Overgaard J, Høyer M, Lindegaard JC, Muren L. 2010. Biology-guided adaptive radiation therapy - presence or future?. Acta Oncologica. 49(7):884-887. https://doi.org/10.3109/0284186X.2010.516010
Elstrøm UV, Wysocka BA, Muren LP, Petersen JBB, Grau C. 2010. Daily kV cone-beam CT and deformable image registration as a method for studying dosimetric consequences of anatomic changes in adaptive IMRT of head and neck cancer. Acta Oncologica. 49(7):1101-8. https://doi.org/10.3109/0284186X.2010.500304
Partridge M, Yamamoto T, Grau C, Høyer M, Muren L. 2010. Imaging of normal lung, liver and parotid gland function for radiotherapy. Acta Oncologica. 49(7):997-1011. https://doi.org/10.3109/0284186X.2010.504735
Bøjen A, Grau C. 2010. Virtual reality in radiation therapy training. Surgical Oncology. https://doi.org/10.1016/j.suronc.2010.07.004
Overgaard J, Mohanti BK, Begum N, Ali R, Agarwal JP, Kuddu M, Bhasker S, Tatsuzaki H, Grau C. 2010. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial. Lancet Oncology. 11(6):553-60. https://doi.org/10.1016/S1470-2045(10)70072-3
Tanderup K, Georg D, Pötter R, Kirisits C, Grau C, Lindegaard JC. 2010. Adaptive management of cervical cancer radiotherapy. Seminars in Radiation Oncology. 20(2):121-9. https://doi.org/10.1016/j.semradonc.2009.11.006
Thorup C, Sebbesen L, Danø H, Leetmaa M, Andersen M, von Buchwald C, Kristensen CA, Bentzen J, Godballe C, Johansen J, Grau C, Andersen M. 2010. Carcinoma of the nasal cavity and paranasal sinuses in Denmark 1995-2004. Acta Oncologica. 49(3):389-94. https://doi.org/10.3109/02841860903428176
Toustrup K, Lambertsen K, Ulhøi BP, Sørensen L, Sørensen HB, Grau C. 2010. Accelererede udrednings- og behandlingsforløb for patienter med hoved-hals-kræft. Ugeskrift for Laeger. 172(4):279-284.
Junge AG, Risør MB, Toustrup K, Grau C. 2010. Hoved-hals-kræft-patienters oplevelse af accelererede patientforløb. Ugeskrift for Laeger. 172(4):274-278.
Kopek N, Paludan M, Petersen J, Hansen AT, Grau C, Høyer M. 2009. Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer. Radiotherapy & Oncology. 93(3):402-407. https://doi.org/10.1016/j.radonc.2009.06.002
Agger A, von Buchwald C, Madsen AR, Yde J, Lesnikova I, Christensen CB, Foghsgaard S, Christensen TB, Hansen HS, Larsen S, Bentzen J, Andersen E, Andersen LJ, Grau C. 2009. Squamous cell carcinoma of the nasal vestibule 1993-2002: a nationwide retrospective study from DAHANCA. Head & Neck (Print Edition). 31(12):1593-9. https://doi.org/10.1002/hed.21132
Søndergaard J, Høyer M, Petersen JB, Wright P, Grau C, Muren L. 2009. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy. Acta Oncologica. 48(2):238-244. https://doi.org/10.1080/02841860802251575
Noe KØ, Tanderup K, Lindegaard JC, Grau C, Sørensen TS. 2008. GPU accelerated viscous-fluid deformable registration for radiotherapy. Studies in Health Technology and Informatics. 132:327-32.
Madsen AR, Gundgaard MG, Hoff C, Maare C, Holmboe P, Knap M, Thomsen LL, Buchwald C, Hansen HS, Bretlau P, Grau C. 2008. Cancer of the external auditory canal and middle ear in Denmark from 1992 to 2001. Head & Neck (Print Edition). 30(10):1332-8. https://doi.org/10.1002/hed.20877
Grau C, Muren L, Høyer M, Lindegaard J, Overgaard J. 2008. Image-guided adaptive radiotherapy - integration of biology and technology to improve clinical outcome. Acta Oncologica. 47(7):1182-1185. https://doi.org/10.1080/02841860802282802
Thomsen MS, Berg M, Nielsen HM, Pedersen AN, Overgaard M, Ewertz M, Block T, Brodersen HJ, Caldera C, Jakobsen E, Kamby C, Kjaer-Kristoffersen F, Klitgaard D, Nielsen MM, Stenbygaard L, Zimmermann SJ, Grau C, Danish Breast Cancer Cooperative Group. 2008. Post-mastectomy radiotherapy in Denmark: from 2D to 3D treatment planning guidelines of The Danish Breast Cancer Cooperative Group. Acta Oncologica. 47(4):654-61. https://doi.org/10.1080/02841860801975000
Johansen J, Buus S, Loft A, Keiding S, Overgaard M, Hansen HS, Grau C, Bundgaard T, Kirkegaard J, Overgaard J. 2008. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head & Neck (Print Edition). 30(4):471-8. https://doi.org/10.1002/hed.20734
Wright P, Redpath AT, Høyer M, Grau C, Muren L. 2008. The normal tissue sparing potential of adaptive strategies in radiotherapy of bladder cancer. Acta Oncologica. 47(7):1382-1389. https://doi.org/10.1080/02841860802266763
Elstroem UV, Grau C. 2007. E11: In-room image-guidance technologies for adaptive radiotherapy. Strahlentherapie und Onkologie. 183(SUPPL. 2):61-63. https://doi.org/10.1007/s00066-007-2017-2
Jensen K, Lambertsen K, Grau C. 2007. Late swallowing dysfunction and dysphagia after radiotherapy for phartynx cancer: frequency, intensity and correlation with dose and volume parameter. Journal of the European Society for Therapeutic Radiology an Oncology. 85(1):74-82.
Jensen K, Lambertsen K, Grau C. 2007. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiotherapy & Oncology. 85(1):74-82. https://doi.org/10.1016/j.radonc.2007.06.004
Jensen K, Overgaard M, Grau C. 2007. Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. Radiotherapy and Oncology. 85(1):90-97.
Jensen K, Overgaard M, Grau C. 2007. Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. Radiotherapy & Oncology. 85(1):90-7. https://doi.org/10.1016/j.radonc.2007.06.005
Jensen K, Lambertsen K, Torkov P, Dahl M, Bonde Jensen A, Grau C. 2007. Patient assessed symptoms are poor predictors of objective findings. Results from a cross sectional study in patients treated with radiotherapy for pharyngeal cancer. Acta Oncologica. 46(8):1159-1168.
Jensen K, Lambertsen K, Torkov P, Dahl M, Jensen AB, Grau C. 2007. Patient assessed symptoms are poor predictors of objective findings. Results from a cross sectional study in patients treated with radiotherapy for pharyngeal cancer. Acta Oncologica. 1-10. https://doi.org/10.1080/02841860701491041
Jensen K, Lambertsen K, Torkov P, Dahl M, Jensen AB, Grau C. 2007. Patient assessed symptoms are poor predictors of objektive findings. Results form a cross sectional study in patients treated with radiotherapy for pharyngeal cancer. Acta Oncologica. 46(8):1159-1168.
Overgaard J, Hoff C, Sand Hansen H, Specht L, Overgaard M, Grau C, Andersen E, Johansen J, Andersen LJ, Evensen J. 2007. Randomized study of the importance of Novel Erythropoiesis Stimulating Protein (Aranesp (R)) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) - the Danish Head and Neck Cancer Group DAHANCA 10 randomized trial. European Journal of Cancer Supplements. 5(6):7.
Jensen K, Jensen AB, Grau C. 2007. Smoking has a negative impact upon health related quality of life after treatment for head and neck cancer. Oral Oncology. 43(2):187-192.
Tanderup K, Hellebust TP, Honoré HB, Nielsen SK, Olsen DR, Grau C, Lindegaard JC. 2006. Dose optimisation in single plane interstitial brachytherapy. Radiotherapy & Oncology. 81(1):105-11. https://doi.org/10.1016/j.radonc.2006.08.021
Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. 2006. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. Journal of Clinical Oncology. 24(15):2268-2275. https://doi.org/10.1200/JCO.2005.02.8738
Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. 2006. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. Radiotherapy & Oncology. 79(2):147-55. https://doi.org/10.1016/j.radonc.2006.04.006
Buus S, Grau C, Munk OL, Rodell A, Jensen K, Mouridsen K, Keiding S, Jensen K. 2006. Individual radiation response of parotid glands investigated by dynamic 11C-methionine PET. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 78(3):262-9. https://doi.org/10.1016/j.radonc.2006.02.013
Jensen K, Bonde Jensen A, Grau C, Jensen K. 2006. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 78(3):298-305. https://doi.org/10.1016/j.radonc.2006.02.005
Jensen K, Jensen AB, Grau C. 2006. A cross sectional quality of life study of 116 recurrence free head and neck cancer patients. The first use of EORTC H&N35 in Danish. Acta Oncologica. 45(1):28-37. https://doi.org/10.1080/02841860500417536
Høyer M, Roed H, Traberg Hansen A, Ohlhuis L, Petersen J, Nellemann H, Berthelsen AK, Grau C, Engelholm SA, Von der Maase H. 2006. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncologica. 45(7):823-30. https://doi.org/10.1080/02841860600904854
Bilde A, von Buchwald C, Johansen J, Bastholt L, Sørensen JAHM, Holst PM, Krogdahl A, Hansen HS, Specht L, Kirkegaard J, Andersen EV, Bentzen JKD, Hjort-Sørensen C, Andersen LJ, Nielsen BA, Bundgaard T, Overgaard M, Grau C, Danish Society for Head and Neck Oncology. 2006. The Danish national guidelines for treatment of oral squamous cell carcinoma. Acta Oncologica. 45(3):294-9. https://doi.org/10.1080/02841860600592998
Grau C, Høyer M, Lindegaard JC, Overgaard J. 2006. The emerging evidence for Stereotactic Body Radiotherapy. Acta Oncologica. 45(7):771-774. https://doi.org/10.1080/02841860600943290
Jensen K, Bonde Jensen A, Grau C. 2006. A cross sectional quality of life study of 116 recurrence free head and neck cancer patients. The first use of EORTC HN35 in Danish. Acta Oncologica. 45(1):28-37.
Paludan M, Traberg Hansen A, Petersen J, Grau C, Høyer M, Høyer M. 2006. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?. Acta oncologica (Stockholm, Sweden). 45(7):818-22. https://doi.org/10.1080/02841860600915314
Paludan M, Hansen AT, Petersen JBB, Grau C, Høyer M. 2006. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?. Acta Oncologica. 45(7):818-822. https://doi.org/10.1080/02841860600915314
Andreassen CN, Lindegaard J, Grau C. 2006. Bivirkninger ved strålebehandling for hoved-hals-cancer. Maanedsskrift for Praktisk Laegegerning. 84:553-560.
Primdahl H, Nielsen AL, Larsen S, Andersen E, Ipsen M, Lajer C, Vestermark LW, Andersen LJ, Hansen HS, Overgaard M, Overgaard J, Grau C. 2006. Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx and pharynx: A Danish nationwide survey from DAHANCA. Acta Oncologica. 45:156-161.
Primdahl H, Nielsen AL, Larsen S, Andersen E, Ipsen M, Lajer C, Vestermark LW, Andersen LJ, Hansen HS, Overgaard M, Overgaard J, Grau C, DAHANCA. 2006. Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA. Acta Oncologica. 45(2):156-161. https://doi.org/10.1080/02841860500423948
Tanderup K, Hellebust TP, Honoré HH, Nielsen SK, Olsen DR, Grau C, Lindegaard J. 2006. Dose optimisation in single plane interstitial brachytherapy. Radiother. Oncol. (81):105-111. https://doi.org/10.1016/j.radonc.2006.08.021
Tanderup K, Olsen DR, Grau C. 2006. Dose painting: art or science?. Radiother. Oncol. (79):245-248. https://doi.org/10.1016/j.radonc.2006.05.002
Grau C, Høyer M. 2006. Højpræcisions konform strålebehandling. Månedsskr. prakt. lægegerning. (84):291-296.
Høyer M, Roed H, Hansen AT, Ohlhuis L, Petersen JBB, Nellemann HM, Berthelsen AK, Grau C, Engelholm SA, Maase HVD. 2006. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta. Oncol. (45):823-830. https://doi.org/10.1080/02841860600904854
Høyer M, Roed H, Hansen AT, Ohlhuis L, Petersen JBB, Nellemann HM, Berthelsen AK, Grau C, Engelholm SA, Maase HVD. 2006. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. (66/4):S128-135. https://doi.org/10.1016/j.ijrobp.2006.01.012
Jensen K, Jensen AB, Grau C. 2006. Smoking has a negative impact upon health related quality of life after treatment for head and neck cancer. Oral Oncology. 43(2):187-92. https://doi.org/10.1016/j.oraloncology.2006.02.006
Grau C. 2006. Strålebehandling af kræft. Månedsskr Prak Lægegern. 84(2):133-138.
Jensen K, Jensen AB, Grau C. 2006. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiotherapy and Oncology. 78(3):298-305.
Jensen K, Jensen AB, Grau C. 2006. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system      and the EORTC quality of life questionnaires. Radiother. Oncol. 78(3):298-305. https://doi.org/10.1016/j.radonc.2006.02.005
Nielsen HM, Overgaard J, Grau C, Christensen JJ, Overgaard M. 2005. Audit of the radiotherapy in the DBCG 82 b&c trials - A validation study of the 1538 patients randomised to postmastectomy radiotherapy. Radiotherapy & Oncology. 76(3):285-292. https://doi.org/10.1016/j.radonc.2005.08.002
Grau C, Høyer M. 2005. High-precision radiotherapy. European Oncology Review. 40-44.
Grau C, Høyer M, Schultz HP. 2005. Ny teknologi giver mere præcis strålebehandling af kræft. Medicus. (2):5-12.
Grau C, Andreassen CN, Jensen K, Lindegaard JC. 2004. Oral complications of radiotherapy in head and neck cancer. Strategies for prevention and management. American Journal of Cancer Research. 3(5):291-298.
Johansen LV, Grau C, Overgaard J. 2004. Nodal control and surgical salvage after primary radiotherapy in 1782 patients with laryngeal and pharyngeal carcinoma. Acta Oncologica. 43(5):486-94.
Buus S, Grau C, Munk OL, Bender D, Jensen K, Keiding S. 2004. 11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancer. Radiotherapy & Oncology. 73(3):289-296. https://doi.org/10.1016/j.radonc.2004.09.009
Grégoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, Chao C, Coche E, Cooper JS, Cosnard G, Eisbruch A, El-Sayed S, Emami B, Grau C, Hamoir M, Lee N, Maingon P, Muller K, Reychler H. 2003. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. Radiotherapy & Oncology. 69(3):227-36.
Grégoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, Chao C, Coche E, Cooper JS, Cosnard G, Eisbruch A, El-Sayed S, Emami B, Grau C, Hamoir M, Lee N, Maingon P, Muller K, Reychler H. 2003. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiotherapy & Oncology. 69(3):227-236. https://doi.org/10.1016/j.radonc.2003.09.011
Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen EV, Bentzen JKD, Bastholt L, Hansen O, Johansen J, Andersen L, Evensen JF. 2003. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet. 362(9388):933-40.
Grau C, Prakash Agarwal J, Jabeen K, Rab Khan A, Abeyakoon S, Hadjieva T, Wahid I, Turkan S, Tatsuzaki H, Dinshaw KA, Overgaard J. 2003. Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial. Radiotherapy & Oncology. 67(1):17-26.
Nielsen HM, Christensen JJ, Aagaard T, Thingholm J, Overgaard M, Grau C. 2003. A simple method to test if the internal mammary lymph nodes are covered by the wide tangent technique in radiotherapy for high-risk breast cancer. Clinical Oncology. 15(1):17-24.
Andreassen CN, Grau C, Lindegaard JC. 2003. Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy. Seminars in Radiation Oncology. 13(1):62-72. https://doi.org/10.1053/srao.2003.50006
Hald J, Overgaard J, Grau C. 2003. Evaluation of objective measures of smoking status--a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy. Acta Oncologica. 42(2):154-9.
Johansen LV, Grau C, Overgaard J. 2003. Laryngeal carcinoma--multivariate analysis of prognostic factors in 1252 consecutive patients treated with primary radiotherapy. Acta Oncologica. 42(7):771-8.
Grau C, Johansen LV, Hansen HS, Andersen EV, Godballe C, Andersen LJ, Hald J, Møller H, Overgaard M, Bastholt L, Greisen O, Harbo G, Hansen O, Overgaard J. 2003. Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA. Head & Neck (Print Edition). 25(9):711-6. https://doi.org/10.1002/hed.10237
Friis P, Grau C, Pedersen U, Bundgaard T. 2003. Squamous cell carcinoma of the oral cavity: Analysis of treatment and prognosis. Oral Oncology. 9:117-125.
Honoré HB, Bentzen S, Møller K, Grau C. 2002. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. Radiotherapy & Oncology. 65(1):9-16.
Andersen GH, Bundgaard T, Overgaard J, Grau C. 2002. Comparison of two T-classification systems for sino-nasal carcinoma. Clinical Otolaryngology. 27(4):254-9.
Johansen LV, Grau C, Overgaard J. 2002. Supraglottic carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. International Journal of Radiation Oncology, Biology, Physics. 53(4):948-58.
Bundgaard T, Rossen K, Henriksen SD, Charabi SA, Søgaard H, Grau C. 2002. Histopathologic parameters in the evaluation of T1 squamous cell carcinomas of the oral cavity. Head & Neck (Print Edition). 24(7):656-60. https://doi.org/10.1002/hed.10120
Johansen LV, Grau C, Overgaard J. 2002. Glottic carcinoma--patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiotherapy & Oncology. 63(3):257-67.
Grau C, von Buchwald C. 2002. Nye computerbaserede behandlingsmuligheder ved hoved-halscancer: IMRT og CAS. Dansk Selskab for Hoved- og Halsonkologi. Ugeskrift for Laeger. 164(12):1659.
Grau C, Buchwald C. 2002. Nye computerbaserede behandlingsmuligheder ved hoved-hals cancer: IMRT og CAS: The Danish Society of Head and Neck Oncology. Ugeskrift for Laeger. 164(12).
Ladekarl M, Grau C, Andersen J. 2001. Nye behandlingsperspektiver ved duktalt carcinoma in situ mammae. Ugeskrift for Laeger. 163(37):5014-7.
Grau C, Johansen LV, Jakobsen J, Geertsen PF, Andersen EV, Jensen BB. 2001. Lymfeknudemetastaser på halsen fra ukendt primaertumor. En landsdaekkende 20-års opgørelse fra Dansk Selskab for Hoved- og Halsonkologi. Ugeskrift for Laeger. 163(10):1432-6.
Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. 2001. Lymfeknuder på halsen fra ukendt primær tumor. En landsdækkende 20-års opgørelse fra Dansk Selskab for Hoved-og Halsonkologi. Cervical lymph node metastases from unknown primary tumours. Ugeskrift for Laeger. 163(10):1432-1436.
Grau C, Jakobsen MH, Harbo G, Svane-Knudsen V, Wedervang K, Larsen SK, Rytter C. 2001. Sino-nasal cancer in Denmark 1982-1991--a nationwide survey. Acta Oncologica. 40(1):19-23.
Johansen LV, Grau C, Overgaard J. 2001. Squamous cell carcinoma of the nasopharynx--an analysis of treatment results in 149 consecutive patients. Acta Oncologica. 40(7):801-9.
Grau C, Johansen LV, Jacobsen J, nullbehalfoftheDanishSocietyforHeadandNeckOncology O. 2001. Karcinommetastase på halsen fra ukendt primær tumor. Udredning, behandling og efterkontrol. Klaringsrapport: National recommendations for management of cervical lymph node metastases: National recommendations for management of cervical lymph node metastases. Ugeskrift for Laeger. 7911-7016.
Ladekarl M, Grau C, Andersen J. 2001. Nye behandlingsperspektiver ved duktalt carcinoma in situ mammae: New therapeutic perspectives in breast ductal carcinoma in situ. Ugeskrift for Laeger. 163(37):5014-5017.
Ehrnrooth E, Grau C, Zachariae R, Andersen J. 2001. Randomized trial of opiods versus tricyclic antidepressants for radiation induced mucosistis pain in head and neck cancer. Acta Oncologica. 40(6):745-750.
Ehrnrooth E, Grau C, Zachariae R, Andersen J. 2001. Randomized trial of opioids versus tricyclic antidepressants for radiation-induced mucositis pain in head and neck cancer. Acta Oncologica. 40(6):745-50.
Lindegaard JC, Grau C. 2000. Has the outlook improved for amifostine as a clinical radioprotector?. Radiotherapy & Oncology. 57(2):113-8.
Grau C, Johansen LV, Jakobsen J, Geertsen PF, Andersen E, Jensen BB. 2000. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiotherapy & Oncology. 55(2):121-9.
Jackson JS, Olivotto IA, Wai M D E, Grau C, Mates D, Ragaz J. 2000. A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma. Cancer. 88(8):1852-62.
Johansen LV, Grau C, Overgaard J. 2000. Hypopharyngeal squamous cell carcinoma--treatment results in 138 consecutively admitted patients. Acta Oncologica. 39(4):529-36.
Johansen LV, Grau C, Overgaard J. 2000. Squamous cell carcinoma of the oropharynx--an analysis of treatment results in 289 consecutive patients. Acta Oncologica. 39(8):985-94.
Overgaard J, Alsner J, Eriksen J, Horsman MR, Grau C. 2000. Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck. Rays. 25(3):313-9.
Grau C, Specht LK, Hansen HS, Overgaard M, Overgaard J. 1997. Centraliseret efterkontrol af patienter behandlet for hoved-halskraeft. Ugeskrift for Laeger. 159(8):1104-8.
Harbo G, Grau C, Bundgaard T, Overgaard M, Elbrønd O, Søgaard H, Overgaard J. 1997. Cancer of the nasal cavity and paranasal sinuses. A clinico-pathological study of 277 patients. Acta Oncologica. 36(1):45-50.
Olive PL, Horsman MR, Grau C, Overgaard J. 1997. Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay. British Journal of Cancer. 76(6):694-9.
Grau C, Overgaard J. 1996. Postirradiation sensorineural hearing loss: a common but ignored late radiation complication. International Journal of Radiation Oncology, Biology, Physics. 36(2):515-7. https://doi.org/10.1016/S0360-3016(96)00346-X
Hansen O, Grau C, Bentzen SM, Overgaard J. 1996. Repopulation in the SCCVII squamous cell carcinoma assessed by an in vivo-in vitro excision assay. Radiotherapy & Oncology. 39(2):137-44. https://doi.org/10.1016/0167-8140(96)01728-8
Nordsmark M, Grau C, Horsman MR, Jörgensen HS, Overgaard J. 1995. Relationship between tumour oxygenation, bioenergetic status and radiobiological hypoxia in an experimental model. Acta Oncologica. 34(3):329-34.
Horsman MR, Grau C, Overgaard J. 1995. Reoxygenation in a C3H mouse mammary carcinoma. The importance of chronic rather than acute hypoxia. Acta Oncologica. 34(3):325-8.
Grau C, Høyer M, Overgaard J. 1994. The in vivo interaction between vincristine and radiation in a C3H mammary carcinoma and the feet of CDF1 mice. International Journal of Radiation Oncology, Biology, Physics. 30(5):1141-1146. https://doi.org/10.1016/0360-3016(94)90321-2
Grau C, Nordsmark M, Khalil AA, Horsman MR, Overgaard J. 1994. Effect of carbon monoxide breathing on hypoxia and radiation response in the SCCVII tumor in vivo. International Journal of Radiation Oncology, Biology, Physics. 29(3):449-54.
Horsman MR, Khalil AA, Siemann DW, Grau C, Hill SA, Lynch EM, Chaplin DJ, Overgaard J. 1994. Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. International Journal of Radiation Oncology, Biology, Physics. 29(3):439-42. https://doi.org/10.1016/0360-3016(94)90434-0
Grau C, Khalil AA, Nordsmark M, Horsman MR, Overgaard J. 1994. The relationship between carbon monoxide breathing, tumour oxygenation and local tumour control in the C3H mammary carcinoma in vivo. British Journal of Cancer. 69(1):50-7.
Horsman MR, Khalil AA, Nordsmark M, Grau C, Overgaard J. 1993. Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model. Radiotherapy & Oncology. 28(1):69-71.
Grau C. 1993. Stråleskader i medulla spinalis. Ugeskrift for Laeger. 155(4):208-11.
Grau C, Møller K, Overgaard M, Overgaard J, Elbrønd O. 1992. Auditory brain stem responses in patients after radiation therapy for nasopharyngeal carcinoma. Cancer. 70(10):2396-401.
Overgaard J, Nielsen JE, Grau C. 1992. Effect of carboxyhemoglobin on tumor oxygen unloading capacity in patients with squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics. 22(3):407-10. https://doi.org/10.1016/0360-3016(92)90842-6
Grau C, Overgaard J. 1992. Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ. Cancer Chemotherapy and Pharmacology. 30(4):277-80.
Grau C, Horsman MR, Overgaard J. 1992. Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing. International Journal of Radiation Oncology, Biology, Physics. 22(3):415-419. https://doi.org/10.1016/0360-3016(92)90844-8
Grau C, Horsman MR, Overgaard J. 1992. Influence of carboxyhemoglobin level on tumor growth, blood flow, and radiation response in an experimental model. International Journal of Radiation Oncology, Biology, Physics. 22(3):421-424. https://doi.org/10.1016/0360-3016(92)90845-9
Mao HS, Grau C, Overgaard J. 1992. Interaction of misonidazole, hyperthermia, and irradiation in a C3H mammary carcinoma and its surrounding skin in vivo. International Journal of Radiation Oncology, Biology, Physics. 22(1):115-122.
Lindegaard JC, Grau C, Overgaard J. 1991. Effect of step-down heating on the interaction between heat and radiation in a C3H mammary carcinoma in vivo. International Journal of Radiation Biology. 60(4):707-721.
Grau C, Møller K, Overgaard M, Overgaard J, Elbrønd O. 1991. Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics. 21(3):723-728.
Bentzen SM, Grau C. 1991. Direct estimation of the fraction of hypoxic cells from tumour--control data obtained under aerobic and clamped conditions. International Journal of Radiation Biology. 59(6):1435-1440.
Grau C, Overgaard J. 1991. Radiosensitizing and cytotoxic properties of mitomycin C in a C3H mouse mammary carcinoma in vivo. International Journal of Radiation Oncology, Biology, Physics. 20(2):265-269.
Overgaard J, Radacic MM, Grau C. 1991. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo. Cancer Research. 51(2):707-711.
Overgaard J, Grau C, Lindegaard JC, Horsman MR. 1991. The potential of using hyperthermia to eliminate radioresistant hypoxic cells. Radiotherapy & Oncology. 20 (Suppl 1):113-116.
Grau C, Overgaard J. 1990. The influence of radiation dose on the magnitude and kinetics of reoxygenation in a C3H mammary carcinoma. Radiation Research. 122(3):309-15.
Grau C, Bentzen SM, Overgaard J. 1990. Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo. British Journal of Cancer. 61(1):61-4.
Grau C, Zachariae C, Mao HS, Overgaard J. 1990. The in vivo response of a C3H mammary carcinoma to treatment with misonidazole, cyclophosphamide and radiation. Acta Oncologica. 29(6):769-74.
Grau C, Overgaard J. 1988. Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay. Radiotherapy & Oncology. 13(4):301-9.